nasdaq_markets · 2026-08-25
(RTTNews) - Tuesday, McKesson Corp. (MCK) announced an agreement to acquire Precision Medicine Group, LLC, a global provider of clinical research and biopharma commercialization services, for approximately $2.25 billion.
Read the original at nasdaq_markets ↗
Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.
Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。